During the past decade, Neurobehavioral Medicine Group conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurobehavioral Medicine Group" #1 sponsor was "Sunovion" with 7 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 3 trials sponsored, "Emalex Biosciences Inc." with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Shire" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurobehavioral Medicine Group" #1 collaborator was "Otsuka America Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Neurobehavioral Medicine Group" are "Attention Deficit Hyperactivity Disorder" (3 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (2 trials), "Autistic Disorder" (2 trials), "Depressive Disorder, Major" (2 trials) and "Insomnia" (2 trials). Many other conditions were trialed in "Neurobehavioral Medicine Group" in a lesser frequency.

Most popular intervention types in "Neurobehavioral Medicine Group" are "Drug" (18 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Aripiprazole" (4 trials), "Dasotraline" (2 trials), "Ecopipam" (2 trials) and "Lurasidone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Neurobehavioral Medicine Group" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Neurobehavioral Medicine Group". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Neurobehavioral Medicine Group, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Neurobehavioral Medicine Group, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".

Neurobehavioral Medicine Group has several departments that took part in Clinical trials: "Neurobehavioral Medicine Group, Clinical Trials Division" - 2 trials